secwatch.observer — SEC 8-K summary
======================================

Issuer:     STRATA Skin Sciences, Inc. (SSKN)
CIK:        0001051514
Form:       8-K
Filed at:   2024-01-08T23:59:59+00:00
Accession:  0001140361-24-001339
Event type: other
Sentiment:  positive
Materiality: 0.25
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

STRATA Skin Sciences presents TheraClear®X acne study at Maui Derm 2024
-----------------------------------------------------------------------

- Poster reports one treatment session using TheraClear®X with needle insert for cystic and papular acne.
- Majority of lesions achieved ≥50% clearing by 1-2 weeks; average reduction score 3.5 (50-75% reduction).
- Most frequent adverse event was mild hyperpigmentation; erythema, edema, flaking seen in ≤10% of lesions.
- Conference takes place Jan 22-26, 2024 at Grand Wailea in Maui, Hawaii.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1051514/000114036124001339/0001140361-24-001339-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1051514/000114036124001339/ef20018284_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-001339

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer